EMILY LAND: Open Payments
NPI 1972258366 · MOBERLY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 74 payments from 21 companies in 2025. Trend: 2023 $2,023 · 2024 $2,640 · 2025 $1,231
Food & beverage: $1,231
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $280 |
| ABBVIE INC. | 14 | $224 |
| Novo Nordisk Inc | 18 | $189 |
| Amgen Inc. | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Lilly USA, LLC | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| PFIZER INC. | 2 | $42 |
| Verona Pharma, Inc. | 2 | $37 |
Products named: AIRSUPRA, QULIPTA, BREZTRI, Wegovy, FANAPT, Ozempic, VRAYLAR, CAPLYTA.
Industry payments across MO — which companies pay providers there.
